STAT+ | FDA Petitioned to Recall Batches of Metformin Diabetes Pill Over a Possible Carcinogen
STAT+ released an article titled, "FDA petitioned to recall batches of metformin diabetes pill over a possible carcinogen." This piece highlights Valisure's March 2, 2020, announcement of detecting high levels of N-Nitrosodimethylamine (NDMA) in specific lots of the drug metformin, a prescription medication used to control high blood sugar in adults and adolescents with type 2 diabetes.
View the full article via STAT+ here.
